Biomedical Engineering Reference
In-Depth Information
22. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer
(EYE001) for the treatment of exudative age-related macular degeneration. Retina
2002; 22:143-52.
23. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascu-
larization secondary to age-related macular degeneration: phase II study results.
Ophthalmology 2003; 110:979-86.
24. The Eyetech Study Group. Anti-vascular endothelial growth factor therapy for
subfoveal choroidal neovascularisation secondary to age related macular degener-
ation, phase II study results. Ophthalmology 2003; 110:979-86.
25. The Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy
for treatment of subfoveal neovascularisation in age related macular degeneration:
twelve-month clinical outcomes. Ophthalmology 2003; 110:2372-85.
26. Haim M. Epidemiology of retinitis pigmentosa. Acta Ophthalmol Scand Suppl 2002;
233:1-34.
27. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine
model of childhood blindness. Nat Genet 2001; 28(1):92-5.
28. Kicic A, Shen WY, Wilson AS, et al. Differentiation of marrow stromal cells into
photoreceptors in the rat eye. J Neurosci 2003; 23(21):7742-9.
29. Arai S, Thomas BB, Seiler MJ, et al. Restoration of visual responses following
transplantation of intact retinal sheets in rd mice. Exp Eye Res 2004; 79(3):331-41.
30. Kim SY, Sadda S, Humayun MS, et al. Morphometric analysis of the macula in
eyes with geographic atrophy due to age-related macular degeneration. Retina 2002;
22(4):464-70.
31. Kim SY, Sadda S, Pearlman J, et al. Morphometric analysis of the macula in eyes
with disciform age-related macular degeneration. Retina 2002; 22(4):471-7.
32. Humayun MS, Prince M, de Juan EJ, et al. Morphometric analysis of the extramacular
retina from postmortem eyes with retinitis pigmentosa. Invest Ophthalmol Vis Sci
1999; 40(1):143-8.
33. Santos A, Humayun MS, de Juan E, Jr., et al. Preservation of the inner
retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol 1997;
115(4):511-5.
34. Stone JL, Barlow WE, Humayun MS, et al. Morphometric analysis of macular
photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch
Ophthalmol 1992; 110(11):1634-9.
35. Jones BW, Marc RE. Retinal remodeling during retinal degeneration. Exp Eye Res
2005; 81(2):123-37.
36. Jones BW, Watt CB, Frederick JM, et al. Retinal remodeling triggered by photore-
ceptor degenerations. J Comp Neurol 2003; 464(1):1-16.
37. Marc RE, Jones BW. Retinal remodeling in inherited photoreceptor degenerations.
Mol Neurobiol 2003; 28(2):139-47.
38. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration.
Prog Retin Eye Res 2003; 22(5):607-55.
39. Potts AM, Inoue J. The electrically evoked response (EER) of the visual system.
II. Effect of adaptation and retinitis pigmentosa. Invest Ophthalmol Vis Sci 1969;
8(6):605-12.
40. Potts AM, Inoue J. The electrically evoked response of the visual system (EER).
3. Further contribution to the origin of the EER. Invest Ophthalmol Vis Sci 1970;
9(10):814-9.
Search WWH ::
Custom Search